Reaktion #3711

ord-b37387234d9b48f3aa711f14904bb138

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Sonstigethe reaction mixture is evaporated in vacuo to a residue which
  2. 2
    workup.DISSOLUTIONis dissolved in methyl alcohol
  3. 3
    workup.STIRRINGstirred for 1 hour
  4. 4
    Sonstigeevaporated in vacuo to a residue which
  5. 5
    workup.ADDITIONis treated with 2 ml of NH4Cl
  6. 6
    Extraktionextracted with 15 ml of ethyl acetate
  7. 7
    ExtraktionThe organic extract
  8. 8
    Waschenis washed with saturated NaHCO3, brine
  9. 9
    Trocknendried (Na2SO4)
  10. 10
    Filtrationfiltered through hydrous magnesium silicate
  11. 11
    Sonstigethe filtrate evaporated to a residue
  12. 12
    workup.STIRRINGThe residue is stirred with ether-hexanes

Vorschrift

To a stirred solution of 0.10 g of 10,11-dihydro-10-(4-amino-3-methoxybenzoyl)-5H-pyrrolo[2,1-c][1,4]benzodiazepine in 2 ml of methylene chloride is added 60 mg of triethylamine followed by a solution of 56 mg of n-butylsulfonyl chloride in 0.5 ml of methylene chloride. After stirring at room temperature for 2 hours, the reaction mixture is evaporated in vacuo to a residue which is dissolved in methyl alcohol, stirred for 1 hour and evaporated in vacuo to a residue which is treated with 2 ml of NH4Cl and extracted with 15 ml of ethyl acetate. The organic extract is washed with saturated NaHCO3, brine, dried (Na2SO4), filtered through hydrous magnesium silicate and the filtrate evaporated to a residue. The residue is stirred with ether-hexanes to give 0.14 g of light yellow solid. MS(CI): 454 (M+H).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US05733905uspto-grants-1998_03